Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 2494 results found. Search for [ pharma companies in India ]

Results 1 to 21 of 2494
BusinessToday.In
May 13, 2021
Sisodia also said that Delhi's oxygen requirement has also reduced to 582 MT per day from over 700 MT earlier. The central government can reroute the additional oxygen being supplied to Delhi to other states, he said


BusinessToday.In
May 13, 2021
Baricitinib has received 'restricted emergency use approval' from the health ministry's central drugs standard control organisation for use in combination with Remdesivir for treatment of suspected or confirmed COVID-19 patients


BusinessToday.In
May 13, 2021
State Minister CV Ganesan said strict action will be taken against factories and companies that don't take steps to control accidents 


PTI
May 11, 2021
The regulator has also put in place a framework in relation to applicability, constitution and role of the Risk Management Committee (RMC) and eased norms for re-classification of a promoter as a public shareholder


BusinessToday.In
May 11, 2021
The three Indian drugmakers - Cipla Ltd, Lupin Ltd, and Sun Pharma will collaborate with Lilly to manufacture and distribute Baricitinib in India. The drug is approved by the Central Drugs Standard Control Organization (CDSCO) for restricted emergency use in India


Joe C Mathew
May 10, 2021
Lilly said the company is also in discussions with several other Indian manufacturers for the potential grant of additional voluntary licenses. These voluntary licensing agreements will ensure high quality manufacturing and accessibility of Baricitinib


Joe C Mathew
May 7, 2021
The protestors asked the government to license vaccine production widely to more pharma companies with technological capabilities, instead of a few companies, provide regulatory clearance to start local production of Sputnik V COVID-19 vaccine


BusinessToday.In
May 6, 2021
RBI Governor Shaktikanta Das announced had a Rs 50,000 lending programme to ramp up COVID-19-related healthcare infrastructure amid massive second wave ravaging India


BusinessToday.In
May 6, 2021
The macro impact of the scheme can be gauged from the fact that Rs 50,000 crore is roughly 9% of India's total health expenditure of Rs 6 lakh crore under private final consumption expenditure in 2019-20, according to SBI Ecowrap


Anand Adhikari
May 5, 2021
The measures announced by the Reserve Bank Governor Shaktikanta Das are timely and directed at certain segments


Rai Vinaykumar
May 4, 2021
As the number of vaccinated people is increasing, new COVID-19 cases and hospitalisations have started going down in US.


BusinessToday.In
May 4, 2021
Serum Institute of India (SII), which is known globally for its vaccine production capacity is among 20 Indian companies across sectors (healthcare, biotech and software services) to announce massive investment plans in the UK


Joe C Mathew
May 3, 2021
The Drugs Controller General of India (DCGI) has also asked enforcement authorities of states and Centre to take immediate action on incidence of black-marketing, hoarding and overcharging of Remdesivir


PTI
May 3, 2021
Petitioner Dincur Bajaj said since the export of Remdesivir has been banned by the Centre, the companies which were producing it for export be permitted to manufacture and sell it in the domestic market


Joe C Mathew
May 2, 2021
RSS affiliate Swadeshi Jagran Manch (SJM) called for the facilitation of technology transfer of vaccines, including the trade secrets to all potential manufacturers to scale up production of Covaxin and Covishield


BusinessToday.In
May 1, 2021
Developed by Russia's Gamaleya Research Institute of Epidemiology and Microbiology, Sputnik V was approved by Indian drug regulator last month.


BusinessToday.In
May 1, 2021
States like Uttar Pradesh, Gujarat and Maharashtra have begun COVID-19 vaccination for all adults above the age of 18 years from Saturday, May 1; here's what you need to know


BusinessToday.In
April 30, 2021
Gilead will dispatch 75,000 to 1,00,00 vials in the next one or two days. Further, 100,000 will also be supplied before or by May 15. EVA Pharma will supply 10,000 vials initially, followed by 50,000 every 15 days or till July


PTI
April 29, 2021
The public interest litigation (PIL), filed last week by Mumbai-based advocate Fayzan Khan and three law students, had challenged the different rates of COVID-19 vaccines for the Centre and state governments


Team BT
New Delhi, April 29, 2021
Industrialised states like Maharashtra, Gujarat and Delhi have been the most affected in the second Covid wave, resulting in large-scale migration of labour and posing a bumpy road ahead for businesses


PAGES 1 OF 125  12345